Tieto Oyj TIETO.HE
Composite 60/100; the shares have moved about 27% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 21/100 — a strong mark against it.
Valuation ranks 87/100 — a strong point in its favour. Income ranks 85/100 — a strong point in its favour. Balance-sheet strength ranks 65/100 — a moderate point in its favour.
Growth ranks 21/100 — a strong mark against it.
What the company does Tieto Oyj provides software and digital engineering services across banking, healthcare, industrial, and public sectors. Its segments include Tieto Tech Consulting, Tieto Banktech, Tieto Caretech, and Tieto Indtech Services, serving industries like finance, pulp/paper, and healthcare.
Key financials ROE 21.1%, ROA 7.4%, and ROCE 20.7% indicate strong profitability. Margins: gross 23.4%, operating 26.2%, net 6.7%. Revenue growth is -7.9% and EPS growth is -12.7%, reflecting recent challenges.
Stock health Sideravia scores: Quality 63.2, Growth 24.2, Strength 67.3, Valuation 82.0, Momentum 55.2, Income 90.8. Dividend yield is 4.7% with a 63.0% payout ratio, supported by a strong FCF yield of 20.3%.
Price vs fair value The stock trades at a **PREMIUM of 9.70%** versus our fair-value estimate of 17.25 and a **discount of 0.13%** versus the analyst 12-month target of 19.12. - Valuation metrics (P/E 10.11, EV/EBITDA 6.45) suggest undervaluation relative to peers (Valuation 82.0). - High income score (90.8) and dividend yield (4.7%) may support demand. - Negative revenue (-7.9%) and EPS (-12.7%) growth may justify the premium to fair value. - Strong profitability (ROE 21.1%, ROCE 20.7%) supports valuation resilience.
Looking forward Forward P/E of 8.55 and PEG of 0.47 imply potential upside if growth recovers. Momentum over 12 months is 34.35%, though -12.63% below the 52-week high suggests volatility. Analyst targets align closely with current price, indicating limited near-term upside.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.